156 related articles for article (PubMed ID: 30456413)
21. Beyond dermal exposure: The respiratory tract as a target organ in hazard assessments of cosmetic ingredients.
Thá EL; Canavez ADPM; Schuck DC; Gagosian VSC; Lorencini M; Leme DM
Regul Toxicol Pharmacol; 2021 Aug; 124():104976. PubMed ID: 34139277
[TBL] [Abstract][Full Text] [Related]
22. Safety evaluations under the proposed US Safe Cosmetics and Personal Care Products Act of 2013: animal use and cost estimates.
Knight J; Rovida C
ALTEX; 2014; 31(2):177-208. PubMed ID: 24468774
[TBL] [Abstract][Full Text] [Related]
23. [Mandatory regulations and standards regarding cosmetic botanic ingredients in major countries and regions].
Shen NT; Yuan H; Lin QB; Tang L
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5488-5495. PubMed ID: 32237399
[TBL] [Abstract][Full Text] [Related]
24. [EU-Cosmetics: timetables for the replacement of animal experiments].
Ruhdel IW
ALTEX; 2005; 22(2):117-9. PubMed ID: 15953967
[TBL] [Abstract][Full Text] [Related]
25. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
[TBL] [Abstract][Full Text] [Related]
26. Alternatives to the use of animals in household product and cosmetic testing.
Bruner LH
J Am Vet Med Assoc; 1992 Mar; 200(5):669-73. PubMed ID: 1568909
[No Abstract] [Full Text] [Related]
27. A strategy for systemic toxicity assessment based on non-animal approaches: The Cosmetics Europe Long Range Science Strategy programme.
Desprez B; Dent M; Keller D; Klaric M; Ouédraogo G; Cubberley R; Duplan H; Eilstein J; Ellison C; Grégoire S; Hewitt NJ; Jacques-Jamin C; Lange D; Roe A; Rothe H; Blaauboer BJ; Schepky A; Mahony C
Toxicol In Vitro; 2018 Aug; 50():137-146. PubMed ID: 29499337
[TBL] [Abstract][Full Text] [Related]
28. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
29. Annual Review of Cosmetic Ingredient Safety Assessments--2001/2002.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2003; 22 Suppl 1():1-35. PubMed ID: 12851163
[No Abstract] [Full Text] [Related]
30. A FRAME response to the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects--2010.
Balls M; Clothier R
Altern Lab Anim; 2010 Oct; 38(5):345-53. PubMed ID: 21105753
[TBL] [Abstract][Full Text] [Related]
31. Validation of alternative tests in the European Union.
Balls M
Curr Probl Dermatol; 1995; 23():265-74. PubMed ID: 9035921
[No Abstract] [Full Text] [Related]
32. Animal use in the chemical and product manufacturing sectors - can the downtrend continue?
Curren R
Altern Lab Anim; 2009 Dec; 37(6):623-9. PubMed ID: 20104998
[TBL] [Abstract][Full Text] [Related]
33. Subacute and subchronic toxicity.
Prieto P; Clemedson C; Meneguz A; Pfaller W; Sauer UG; Westmoreland C
Altern Lab Anim; 2005 Jul; 33 Suppl 1():109-16. PubMed ID: 16194144
[No Abstract] [Full Text] [Related]
34. Mercury content in marketed cosmetics: analytical survey in Shijiazhuang, China.
Wang L; Zhang H
Cutan Ocul Toxicol; 2015; 34(4):322-6. PubMed ID: 25594253
[TBL] [Abstract][Full Text] [Related]
35. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
Indans I
Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
[TBL] [Abstract][Full Text] [Related]
36. Genotoxicty and mutagenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():117-30. PubMed ID: 16194145
[No Abstract] [Full Text] [Related]
37. Review of the standards of proof (of safety) for FDA regulated consumer products and how the generally recognized as safe criteria could be applied to cosmetics.
Burdock GA
Regul Toxicol Pharmacol; 2024 May; 149():105603. PubMed ID: 38494042
[TBL] [Abstract][Full Text] [Related]
38. Safety assurance of cosmetics in Japan: current situation and future prospects.
Inomata S
J Oleo Sci; 2014; 63(1):1-6. PubMed ID: 24389794
[TBL] [Abstract][Full Text] [Related]
39. On facing up to risk and uncertainty in relation to animal and non-animal safety testing.
Balls M
Altern Lab Anim; 2006 Dec; 34(6):547-9. PubMed ID: 17266391
[No Abstract] [Full Text] [Related]
40. Safety Assessment of Dialkyl Sulfosuccinate Salts as Used in Cosmetics.
Fiume MM; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
Int J Toxicol; 2016 Nov; 35(3 suppl):34S-46S. PubMed ID: 27913786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
